Friday, July 10, 2026

biotech · Bacterial Infection

4Ammonium Biotech

4Ammonium Biotech drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

EU HQ
3 Employees
EMA registrant Type
Company details
Status
Public
HQ
EU
Employees
3
Programs
1
Drugs
2
Patents
0
Intelligence · Drug Pipeline

4Ammonium Biotech pipeline

Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

4Ammonium Biotech drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

Drug portfolio

2 compounds
  1. Development asset linked to 4Ammonium Biotech in public FDA and regional records.

  2. Development asset linked to 4Ammonium Biotech in public FDA and regional records.